(198) NYX-2925, a NMDA receptor glycine site functional partial agonist, shows efficacy in neuropathic pain that is NMDA and AMPA receptor dependent and appears to be driven through brain, but not spinal, circuitry

Subjects

Subjects :

Anesthesiology and Pain Medicine
Neurology
business.industry
Anesthesia
Neuropathic pain
Glycine
Medicine
NMDA receptor
Neurology (clinical)
AMPA receptor
Pharmacology
business
Partial agonist

Details

ISSN :

15265900

Volume :

18

Database :

OpenAIRE

Journal :

The Journal of Pain

Accession number :

edsair.doi...........0808634205361f6ba029a0b93adf4ca9

Full Text :

https://doi.org/10.1016/j.jpain.2017.02.105